By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Great Basin today announced it has filed for 510(k) clearance of its molecular diagnostic test for Clostridium difficile.

In addition to its application to the US Food and Drug Administration, the Salt Lake City firm said also that it plans to submit an application to the European Union by the end of the year to obtain CE marking for the test, and upon regulatory approvals in the US and Europe, the company will launch its assay and instrument immediately.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.